Viewing Study NCT00000292


Ignite Creation Date: 2025-12-24 @ 3:28 PM
Ignite Modification Date: 2025-12-27 @ 2:38 AM
Study NCT ID: NCT00000292
Status: COMPLETED
Last Update Posted: 2017-01-12
First Post: 1999-09-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Acute Withdrawal From Smoked Cocaine - 9
Sponsor: National Institute on Drug Abuse (NIDA)
Organization:

Study Overview

Official Title: Acute Withdrawal From Smoked Cocaine
Status: COMPLETED
Status Verified Date: 1996-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to develop an experimental paradigm to examine acute withdrawal symptoms from cocaine.
Detailed Description: Although there are clearly identifiable withdrawal syndromes following cessation of a number of abused drugs such as alcohol and heroin, it is unclear whether a withdrawal syndrome follows the cessation of crack cocaine. A laboratory model of withdrawal from smoked (crack) cocaine would provide a safe and systematic method of testing the efficacy of behavioral or pharmacological treatments for withdrawal symptoms following cocaine smoking cessation. Therefore, this study investigated acute behavioral, subjective, and physiological withdrawal symptomatology for 6 hrs following 7 deliveries of 2 dose sized (0.07 vs. 0.4 mg/kg) of smoked cocaine. The behavioral measure was performance on a computerized reaction time task, subjective measures included participant and observer ratings of mood and withdrawal symptomatology, and physiological measures comprised heart rate and blood pressure. It was hypothesized that signs and symptoms of withdrawal from smoked cocaine would be greater following the 0.4 mg/kg dose size, compared to the 0.07 mg/kg dose size.

Study Oversight

Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
P50-09259-9 None None View